Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Travel Grant, 2025, South Korea, Bio Korea, May 6-9

Reference number
Coordinator Salipro Biotech AB
Funding from Vinnova SEK 25 000
Project duration May 2025 - May 2025
Status Completed
Venture Global cooperation 2025

Important results from the project

The project successfully met its initial objectives, including expanding Salipro Biotech’s presence in South Korea, reinforcing existing partnerships, and initiating the discussions of new collaboration opportunities. Additional outcomes included enhanced visibility through presentations and meetings, the establishment of new industry key contacts, and strategic insights that support our long-term strategic growth and contribute to Sweden’s global life science positioning.

Expected long term effects

In the long term, the project is expected to facilitate sustained international collaborations, particularly in South Korea, through strengthened partnerships and new strategic alliances. These relationships may lead to co-development projects and licensing opportunities in the context of Salipro® platform. The outcomes also support Salipro Biotech’s global expansion and contribute to Sweden’s role as a leader in life science innovation and international cooperation.

Approach and implementation

The project was carried out according to plan, with a strong focus on promoting Swedish life sciences—including Salipro Biotech’s presence—in South Korea. Activities such as strategic preparation, targeted networking, meetings, presentations and site visits were well-aligned with the goals. The timeline was followed, no major external issues arose, and the delegation program exceeded expectations by generating new leads and expanding professional networks. Overall the project was successful.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 23 May 2025

Reference number 2025-00775